Musculoskeletal Transplant Foundation Inc is a 501(c)(3) organization based in Edison, New Jersey, registered in 1996, with $509,478,090 in FY2024 revenue. CharityIndex grades it A+, and it directs about 91% of spending to programs.
Revenue (FY2024)
$509.5M
▲ 3.2% vs prior year
Health median: $840K
Expenses (FY2024)
$491.1M
Net assets
$126.3M
Employees
1,309
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Musculoskeletal Transplant Foundation Inc: 91% to programs · $0 to raise $100 earns a A+ on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Musculoskeletal Transplant Foundation Inc: 3 mo reserves · +4% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Musculoskeletal Transplant Foundation Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Musculoskeletal Transplant Foundation Inc: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
We provide innovative human biologic solutions that maximize the gift of donation.
Mtf pays independent research experts to review grant proposals submitted to the organization for validity or merit of the proposed research project and also relationship to mtf's core mission of advancing musculoskeletal transplant science. during 2016, mtf received 71 applicactions for peer review and other grants, 7 projects were approved for funding.
Revenue grew from $430.1M (FY2013) to $509.5M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
3.6%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$323.4M
Total liabilities
$197.1M
Net assets
$126.3M
Salaries & benefits
$153.4M
31% of expenses
Board members
10
8 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $509,478,090▲3.2% | $491,143,940▲0.5% | $126,318,303▲14.6% | $323,446,458▲0.1% | 990 |
| 2023 | $493,471,813▲0.5% | $488,670,194▲4.1% | $110,214,171▲5.8% | $323,206,971▼0.3% | 990 |
| 2022 | $490,881,944▲6.1% | $469,345,667▲5.2% | $104,138,007▲25.5% | $324,084,626▲20.8% | 990 |
| 2021 | $462,633,042▲12.4% | $445,990,309▲7.3% | $82,999,780▲25.3% | $268,255,437▲1.0% | 990 |
| 2020 | $411,628,718▼10.7% | $415,749,192▼8.2% | $66,235,732▲5.2% | $265,715,338▼1.4% | 990 |
| 2019 | $460,828,632▲6.9% | $453,104,239▲4.2% | $62,950,115▲16.0% | $269,396,199▲6.1% | 990 |
| 2018 | $431,011,061▲1.9% | $434,753,803▲2.8% | $54,247,334▲6.0% | $253,935,661▼0.2% | 990 |
| 2017 | $422,813,883 | $422,900,926▼3.2% | $51,154,409▼1.3% | $254,549,114▼0.1% | 990 |
| 2016 | $422,981,266▼1.1% | $436,904,272▼1.4% | $51,803,213▼27.8% | $254,870,681▼1.7% | 990 |
| 2015 | $427,514,347▼1.2% | $443,093,076▲2.3% | $71,716,718▼22.9% | $259,164,742▼3.5% | 990 |
| 2014 | $432,810,716▲0.6% | $433,277,279▼0.4% | $93,040,899▲6.3% | $268,525,493▲2.4% | 990 |
| 2013 | $430,097,937 | $435,208,452▲3.3% | $87,487,293▼18.1% | $262,280,774▲5.2% | 990 |
| 2012 | — | $421,421,593▲6.8% | $106,758,656▼10.8% | $249,216,957▲16.6% | 990 |
| 2011 | — | $394,491,753▲3.0% | $119,727,210▲2.0% | $213,807,248▲4.7% | 990 |
| 2010 | — | $382,909,133 | $117,325,488 | $204,194,569 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Joseph A Yaccarino — $901,884 (0.18% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Joseph A Yaccarino | President / Ceo | 60 | $901,884 |
| Michael J Kawas | Executive Vp/ Cfo | 60 | $661,023 |
| Marc Long | Executive Vp, R & D | 60 | $494,523 |
| Jennifer Birmingham | General Counsel | 60 | $477,283 |
| Sarah Brusch | Executive Specialist - Star | 50 | $476,836 |
| Floyd Vaughan | Executive Specialist - Star | 50 | $458,047 |
| Nathan Rice | Sr. Portfolio Manager | 50 | $456,446 |
| George Herrera | Executive Vp, Donor Services | 60 | $456,333 |
| Michael Oleck | Executive Vp, Processing | 60 | $429,512 |
| Brian Leuthner | Vp and Gm Prs Franchise | 50 | $427,269 |
| Gregory Adams | National Sales Director, Star | 50 | $407,106 |
| Keith Morocko | Vp, Contract Admin | 50 | $406,599 |
| Bradley Bailey | Vp and Gm Ortho Franchise | 50 | $379,683 |
| Kimberly A Rounds | Vp Wound Car | 50 | $290,209 |
| William W Tomford Md | Director | 4 | $75,000 |
| Donald Hackbarth Md | Chairman of the Board | 1 | $35,000 |
| David Kulber Md | Director | 1 | $31,054 |
| Joseph D Zuckerman Md | Director | 1 | $30,000 |
| David R Mcallister Md | Director | 1 | $27,800 |
| Joseph A Buckwalter Md | Director | 1 | $27,500 |
| Contractor | Services | Paid |
|---|---|---|
| Orthofix Us LLC | Tissue Promo | $52,422,736 |
| Conmed Corporation | Tissue Promo | $32,310,627 |
| Depuy Synthes Sales Inc | Tissue Promo | $20,959,705 |
| Kolosis Bio LLC | Tissue Promo | $14,500,215 |
| Centurion Therapeutics Inc | Tissue Promo | $9,160,509 |
1 grant to Musculoskeletal Transplant Foundation Inc totaling $393K, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Texas Health Presbyterian Hospital Dallas | General support | 2019 | $393,045 |
17 grants totaling $694K in FY2024 — showing the 15 largest. All grants made by Musculoskeletal Transplant Foundation Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| Orthopaedic Research and Education Foundation | Scientific research | $110,000 |
| Wake Forest University Health Sciences | Scientific research | $85,700 |
| University of Rochester | Scientific research | $66,667 |
| The Trustees of the Stevens Institute of Technology | Scientific research | $62,500 |
| Regents Univ of California | Scientific research | $49,000 |
| Oregon State University | Scientific research | $41,667 |
| Clemson University Research Foundation | Scientific research | $41,667 |
| Regents of the University of Michigan | Scientific research | $33,333 |
| Case Western Reserve University | Scientific research | $31,250 |
| Virginia Commonwealth University | Scientific research | $25,000 |
| University of Cincinnati | Scientific research | $25,000 |
| Northwestern University | Scientific research | $25,000 |
| The Board of Trustees of the University of Illinois | Scientific research | $20,833 |
| University of Missouri | Career development | $20,833 |
| University of Oregon | Scientific research | $20,833 |
Explore more
Data for Musculoskeletal Transplant Foundation Inc (EIN 22-2803458) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.